ID   DFB
AC   CVCL_9V17
SY   DFBmel
DR   Wikidata; Q54831030
RX   PubMed=9331097;
RX   PubMed=10395702;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
RX   PubMed=9331097;
RA   Salazar-Onfray F., Nakazawa T., Chhajlani V., Petersson M., Karre K.,
RA   Masucci G., Celis E., Sette A., Southwood S., Appella E.,
RA   Kiessling R.;
RT   "Synthetic peptides derived from the melanocyte-stimulating hormone
RT   receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes
RT   that recognize naturally processed peptides on human melanoma
RT   cells.";
RL   Cancer Res. 57:4348-4355(1997).
//
RX   PubMed=10395702; DOI=10.4049/jimmunol.163.2.1037;
RA   Rongcun Y., Salazar-Onfray F., Charo J., Malmberg K.-J., Evrin K.,
RA   Maes H., Kono K., Hising C., Petersson M., Larsson O., Lan L.,
RA   Appella E., Sette A., Celis E., Kiessling R.;
RT   "Identification of new HER2/neu-derived peptide epitopes that can
RT   elicit specific CTL against autologous and allogeneic carcinomas and
RT   melanomas.";
RL   J. Immunol. 163:1037-1044(1999).
//